Top compounds associated with response to RFXANK


Feature Type Standardized
Nominal ANOVA
mRNA BMS-536924 GDSC1000 pan-cancer AAC 0.027 0.4
mRNA Methotrexate FIMM pan-cancer AAC -0.11 0.4
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA CIL56 CTRPv2 pan-cancer AAC 0.04 0.4
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA XAV-939 GDSC1000 pan-cancer AAC 0.028 0.4
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA ML083 CTRPv2 pan-cancer AAC -0.033 0.4
mRNA Bosutinib GDSC1000 pan-cancer AAC 0.028 0.4
Download CSV